These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 17698910)

  • 1. The uridine diphosphate glucuronosyltransferase 2B15 D85Y and 2B17 deletion polymorphisms predict the glucuronidation pattern of androgens and fat mass in men.
    Swanson C; Mellström D; Lorentzon M; Vandenput L; Jakobsson J; Rane A; Karlsson M; Ljunggren O; Smith U; Eriksson AL; Bélanger A; Labrie F; Ohlsson C
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4878-82. PubMed ID: 17698910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men.
    Vandenput L; Mellström D; Lorentzon M; Swanson C; Karlsson MK; Brandberg J; Lönn L; Orwoll E; Smith U; Labrie F; Ljunggren O; Tivesten A; Ohlsson C
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4130-7. PubMed ID: 17711928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.
    Bélanger A; Hum DW; Beaulieu M; Lévesque E; Guillemette C; Tchernof A; Bélanger G; Turgeon D; Dubois S
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):301-10. PubMed ID: 9699884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic aspects of epitestosterone formation and androgen disposition: influence of polymorphisms in CYP17 and UGT2B enzymes.
    Schulze JJ; Lorentzon M; Ohlsson C; Lundmark J; Roh HK; Rane A; Ekström L
    Pharmacogenet Genomics; 2008 Jun; 18(6):477-85. PubMed ID: 18496127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SHBG gene promoter polymorphisms in men are associated with serum sex hormone-binding globulin, androgen and androgen metabolite levels, and hip bone mineral density.
    Eriksson AL; Lorentzon M; Mellström D; Vandenput L; Swanson C; Andersson N; Hammond GL; Jakobsson J; Rane A; Orwoll ES; Ljunggren O; Johnell O; Labrie F; Windahl SH; Ohlsson C
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5029-37. PubMed ID: 16926255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sex steroid levels and cortical bone size in young men are associated with a uridine diphosphate glucuronosyltransferase 2B7 polymorphism (H268Y).
    Swanson C; Lorentzon M; Vandenput L; Labrie F; Rane A; Jakobsson J; Chouinard S; Bélanger A; Ohlsson C
    J Clin Endocrinol Metab; 2007 Sep; 92(9):3697-704. PubMed ID: 17579197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells.
    Chouinard S; Barbier O; Bélanger A
    J Biol Chem; 2007 Nov; 282(46):33466-33474. PubMed ID: 17848572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen glucuronides analysis by liquid chromatography tandem-mass spectrometry: could it raise new perspectives in the diagnostic field of hormone-dependent malignancies?
    Kalogera E; Pistos C; Provatopoulou X; Athanaselis S; Spiliopoulou C; Gounaris A
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Dec; 940():24-34. PubMed ID: 24140653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple roles for UDP-glucuronosyltransferase (UGT)2B15 and UGT2B17 enzymes in androgen metabolism and prostate cancer evolution.
    Gauthier-Landry L; Bélanger A; Barbier O
    J Steroid Biochem Mol Biol; 2015 Jan; 145():187-92. PubMed ID: 24861263
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UDP-glucuronosyltransferase (UGT) 2B15 pharmacogenetics: UGT2B15 D85Y genotype and gender are major determinants of oxazepam glucuronidation by human liver.
    Court MH; Hao Q; Krishnaswamy S; Bekaii-Saab T; Al-Rohaimi A; von Moltke LL; Greenblatt DJ
    J Pharmacol Exp Ther; 2004 Aug; 310(2):656-65. PubMed ID: 15044558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.
    Turgeon D; Carrier JS; Lévesque E; Hum DW; Bélanger A
    Endocrinology; 2001 Feb; 142(2):778-87. PubMed ID: 11159850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide.
    Hu DG; Gardner-Stephen D; Severi G; Gregory PA; Treloar J; Giles GG; English DR; Hopper JL; Tilley WD; Mackenzie PI
    Mol Pharmacol; 2010 Oct; 78(4):714-22. PubMed ID: 20628005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common deletion in the uridine diphosphate glucuronyltransferase (UGT) 2B17 gene is a strong determinant of androgen excretion in healthy pubertal boys.
    Juul A; Sørensen K; Aksglaede L; Garn I; Rajpert-De Meyts E; Hullstein I; Hemmersbach P; Ottesen AM
    J Clin Endocrinol Metab; 2009 Mar; 94(3):1005-11. PubMed ID: 19088161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for oxazepam as an in vivo probe of UGT2B15: oxazepam clearance is reduced by UGT2B15 D85Y polymorphism but unaffected by UGT2B17 deletion.
    He X; Hesse LM; Hazarika S; Masse G; Harmatz JS; Greenblatt DJ; Court MH
    Br J Clin Pharmacol; 2009 Nov; 68(5):721-30. PubMed ID: 19916996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of androgens by UDP-glucuronosyltransferases in the human prostate.
    Barbier O; Bélanger A
    Best Pract Res Clin Endocrinol Metab; 2008 Apr; 22(2):259-70. PubMed ID: 18471784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcitrol (1alpha,25-dihydroxyvitamin D3) inhibits androgen glucuronidation in prostate cancer cells.
    Kaeding J; Bélanger J; Caron P; Verreault M; Bélanger A; Barbier O
    Mol Cancer Ther; 2008 Feb; 7(2):380-90. PubMed ID: 18281521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men.
    Vandenput L; Labrie F; Mellström D; Swanson C; Knutsson T; Peeker R; Ljunggren O; Orwoll E; Eriksson AL; Damber JE; Ohlsson C
    J Bone Miner Res; 2007 Feb; 22(2):220-7. PubMed ID: 17059374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activators of the farnesoid X receptor negatively regulate androgen glucuronidation in human prostate cancer LNCAP cells.
    Kaeding J; Bouchaert E; Bélanger J; Caron P; Chouinard S; Verreault M; Larouche O; Pelletier G; Staels B; Bélanger A; Barbier O
    Biochem J; 2008 Mar; 410(2):245-53. PubMed ID: 17988216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling.
    Chouinard S; Yueh MF; Tukey RH; Giton F; Fiet J; Pelletier G; Barbier O; Bélanger A
    J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):247-53. PubMed ID: 18467088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Androgen sulfation in healthy UDP-glucuronosyl transferase 2B17 enzyme-deficient men.
    Schulze JJ; Thörngren JO; Garle M; Ekström L; Rane A
    J Clin Endocrinol Metab; 2011 Nov; 96(11):3440-7. PubMed ID: 21849521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.